BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22052412)

  • 1. Failure of echinocandin therapy in the treatment of Candida glabrata chorioretinitis.
    Mousselli HA; Norwood J
    Am J Med Sci; 2012 Jan; 343(1):98-100. PubMed ID: 22052412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
    Shorr AF; Wu C; Kothari S
    J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micafungin versus caspofungin in the treatment of Candida glabrata infection: a case report.
    Yamada SM; Tomita Y; Yamaguchi T; Matsuki T
    J Med Case Rep; 2016 Nov; 10(1):316. PubMed ID: 27821139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
    Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
    Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin therapy in a critically ill, morbidly obese patient.
    Zomp A; Bookstaver PB; Ahmed Y; Turner JE; King C
    J Antimicrob Chemother; 2011 Nov; 66(11):2678-80. PubMed ID: 21810839
    [No Abstract]   [Full Text] [Related]  

  • 6. Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases.
    Krcmery V; Demitrovicova A; Kisac P
    J Chemother; 2011 Oct; 23(5):310-1. PubMed ID: 22005067
    [No Abstract]   [Full Text] [Related]  

  • 7. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
    Scott LJ
    Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida glabrata liver abscess and fungemia complicating severe calculus cholecystitis in an immunocompetent nondiabetic host.
    Lima R; Shams W; Kalra S; Borthwick T
    South Med J; 2010 Mar; 103(3):245-7. PubMed ID: 20134390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
    Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
    Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for
    Wright WF; Bejou N; Shields RK; Marr K; McCarty TP; Pappas PG
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31345844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin.
    Bizerra FC; Jimenez-Ortigosa C; Souza AC; Breda GL; Queiroz-Telles F; Perlin DS; Colombo AL
    Antimicrob Agents Chemother; 2014; 58(4):2438-40. PubMed ID: 24468776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of candidemia on caspofungin therapy: a case report.
    Cheung C; Guo Y; Gialanella P; Feldmesser M
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of liposomal amphotericin B refractory Candida glabrata fungaemia in a patient undergoing a stem cell transplantation.
    Veldman BA; Verweij PE; Blijlevens NM
    Neth J Med; 2006 Apr; 64(4):127-9. PubMed ID: 16609161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
    Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
    Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
    Agnelli C; Guinea J; Valerio M; Escribano P; Bouza E; Muñoz P
    Rev Esp Quimioter; 2019 Aug; 32(4):395-397. PubMed ID: 31327188
    [No Abstract]   [Full Text] [Related]  

  • 17. Candida glabrata endophthalmitis treated successfully with caspofungin.
    Sarria JC; Bradley JC; Habash R; Mitchell KT; Kimbrough RC; Vidal AM
    Clin Infect Dis; 2005 Mar; 40(5):e46-8. PubMed ID: 15714407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal resistance does not necessarily affect Candida glabrata fitness.
    Borghi E; Andreoni S; Cirasola D; Ricucci V; Sciota R; Morace G
    J Chemother; 2014 Feb; 26(1):32-6. PubMed ID: 24091025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micafungin treatment and eradication of candiduria among hospitalized patients.
    Gabardi S; Martin S; Sura M; Mohammed A; Golan Y
    Int Urol Nephrol; 2016 Nov; 48(11):1881-1885. PubMed ID: 27587066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.